BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 31, 2020
Distillery Therapeutics

Targeting SMPD1 to treat norovirus

BioCentury | Sep 12, 2019
Distillery Therapeutics

SMPD1 gene therapy for Niemann-Pick disease type A

BioCentury | Aug 31, 2018
Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

BioCentury | Aug 23, 2018
Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

BioCentury | Jun 11, 2018
Preclinical News

Summit identifies two new classes of antibiotics

BioCentury | Jun 14, 2017
Translation in Brief

Connecting microbiome dots

Why bacteriophages could be considered human pathogens
BioCentury | Aug 22, 2016
Emerging Company Profile

Metal smithing

How Forge's metal-binding chemistry can tackle tough metalloenzyme targets
BioCentury | Jul 18, 2013
Targets & Mechanisms

Depressing sphingolipids

Items per page:
1 - 10 of 340